An official website of the United States government
Here's how you know
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Temporal relationship between the onset of worsening kidney function and administration of actinium-225 (225Ac)–prostate-specific membrane antigen (PSMA)617 in our patients is very suggestive of a drug association. Moreover, biopsy findings and their similarity to animal models of this type of injury is strongly suggestive of therapy-related toxicity.
•
Our cases emphasize the need for careful assessment and long-term monitoring of kidney function in patients receiving targeted radionuclide therapy with 225Ac-PSMA617, especially if preexisting kidney impairment is present.
•
As with many newer promising cancer therapies, unforeseen kidney risks may be present and practitioners in both nephrology and oncology must be aware of these potential adverse effects.